This study was designed to explore the potential role of DLG3 in BC progression; our results showed that DLG3 hypermethylation could upregulate RAC1 expression and activate the PI3K/AKT signaling pathway and promote the malignant development of BC cells. This evidence concerns the gene DLG3 and breast cancer.